[1]Patent:CN103755722,2016,B,.Locationinpatent:Paragraph0062-0063
[2]LettersinOrganicChemistry,2018,vol.15,#9,p.739-746
[3]RussianJournalofGeneralChemistry,2016,vol.86,#12,p.2865-2869
[4]Zh.Obshch.Khim.,2016,vol.86,#12,p.2865-2869,5
[5]ChemicalandPharmaceuticalBulletin,1984,vol.32,#12,p.4907-4913
[6]Heterocycles,1998,vol.48,#6,p.1111-1116
[7]Heterocycles,1999,vol.51,#7,p.1563-1572
[8]Patent:US4382892,1983,A,
[9]Patent:CN103360410,2016,B,.Locationinpatent:Paragraph0014;0045;0046
[1]Patent:US5521310,1996,A,
[1]Patent:US5521310,1996,A,
[1]Patent:US5051505,1991,A,
[1]Patent:US5952494,1999,A,
[1]TetrahedronLetters,2001,vol.42,p.6775-6777
[2]ChemicalandPharmaceuticalBulletin,1984,vol.32,p.4907-4913
[1]ChemicalandPharmaceuticalBulletin,1984,vol.32,p.4907-4913
[1]ChemicalandPharmaceuticalBulletin,1984,vol.32,p.4907-4913
[1]ChemicalandPharmaceuticalBulletin,1984,vol.32,p.4907-4913
[1]ChemicalandPharmaceuticalBulletin,1984,vol.32,p.4907-4913
Title: Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2.
Journal: Journal of medicinal chemistry 20061102